BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes

Sultan Abdul-Jawad; Richard Beatson; Thomas Lechmere; Rosalind Graham; Thanussuyah Alaguthurai; Carl Graham; Jennifer Vidler; Austin Kulasekararaj; Piers Em Patten; Katie J Doores; Sheeba Irshad

doi:10.3324/haematol.2021.280337

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes

Sultan Abdul-Jawad, Richard Beatson, Thomas Lechmere, Rosalind Graham, Thanussuyah Alaguthurai, Carl Graham, Jennifer Vidler, Austin Kulasekararaj, Piers Em Patten, Katie J Doores, Sheeba Irshad

King's College London
School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.
Department of Infectious Diseases
School of Immunology and Microbial Sciences and School of Life Course Sciences
Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Department of Haematological Medicine, King's College London School of Medicine, London, UK; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
Breast Cancer Now
GSTT Guy's and St Thomas' NHS Foundation Trust
Cancer Research UK (CRUK) Clinician Scientist
Department of Orthodontics, Queen Mary's Hospital, Sidcup, King's College Hospital NHS Foundation Trust/King's College, London, UK.

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

96 Downloads (Pure)

Abstract

Original language	English
Pages (from-to)	1181-1184
Number of pages	4
Journal	Haematologica
Volume	107
Issue number	5
Early online date	20 Jan 2022
DOIs	https://doi.org/10.3324/haematol.2021.280337
Publication status	Published - May 2022

Access to Document

10.3324/haematol.2021.280337Licence: CC BY-NC

BNT162b2 COVID-19_ABDUL-JAWAD_Publishedonline20January2022_GOLD VoR (CC BY-NC)Final published version, 3.69 MBLicence: CC BY-NC

Cite this

@article{e9c499afe5954d338ddabf36df17ee0f,

title = "BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes",

author = "Sultan Abdul-Jawad and Richard Beatson and Thomas Lechmere and Rosalind Graham and Thanussuyah Alaguthurai and Carl Graham and Jennifer Vidler and Austin Kulasekararaj and Patten, {Piers Em} and Doores, {Katie J} and Sheeba Irshad",

note = "Funding Information: Funding: the SOAP study (IRAS 282337) is sponsored by King{\textquoteright}s College London and GSTT Foundation NHS Trust. It is funded from grants from the KCL Charity funds to SI (PS10822), Cancer Research UK to S.I. (C56773/ A24869). This work was supported by Blood Cancer UK awarded to SI, AK and PP and the Leukaemia & Lymphoma Society (LLS) Award to SI and PP (6631-21). Data sharing statement: data from this study can be made available to other researchers in the field upon request and approval by the study management committee and subject to appropriate data transfer agreements. Requests should be directed to Dr Irshad.",

year = "2022",

month = may,

doi = "10.3324/haematol.2021.280337",

language = "English",

volume = "107",

pages = "1181--1184",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "5",

}

TY - JOUR

T1 - BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes

AU - Abdul-Jawad, Sultan

AU - Beatson, Richard

AU - Lechmere, Thomas

AU - Graham, Rosalind

AU - Alaguthurai, Thanussuyah

AU - Graham, Carl

AU - Vidler, Jennifer

AU - Kulasekararaj, Austin

AU - Patten, Piers Em

AU - Doores, Katie J

AU - Irshad, Sheeba

N1 - Funding Information: Funding: the SOAP study (IRAS 282337) is sponsored by King’s College London and GSTT Foundation NHS Trust. It is funded from grants from the KCL Charity funds to SI (PS10822), Cancer Research UK to S.I. (C56773/ A24869). This work was supported by Blood Cancer UK awarded to SI, AK and PP and the Leukaemia & Lymphoma Society (LLS) Award to SI and PP (6631-21). Data sharing statement: data from this study can be made available to other researchers in the field upon request and approval by the study management committee and subject to appropriate data transfer agreements. Requests should be directed to Dr Irshad.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85129630135&partnerID=8YFLogxK

U2 - 10.3324/haematol.2021.280337

DO - 10.3324/haematol.2021.280337

M3 - Letter

C2 - 35045695

SN - 0390-6078

VL - 107

SP - 1181

EP - 1184

JO - Haematologica

JF - Haematologica

IS - 5

ER -

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes

Abstract

Access to Document

Other files and links

Cite this